News

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients

World-leading surgeons to join iSTAR Medical’s STAR-V study WAVRE, Belgium — 15 July 2021: iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced today that the U.S. Food and Drug Administration (FDA) granted it Investigational Device Exemption (IDE) to start a pivotal trial with MINIjectTM. The STAR-V study will investigate MINIjectTM […]

iSTAR Medical recruits Paul van Hagen as CFO

WAVRE, Belgium — 29 June 2021: iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma treatment, announced today that Paul van Hagen has joined the company as Chief Financial Officer (CFO).

MINIject interim three-year data to be presented at WGC-2021

Interim three-year data on iSTAR Medical’s Minimally Invasive Glaucoma Surgery (MIGS) device MINIjectTM will be presented at the World Glaucoma Congress WGC-21, virtually hosted by the Japan Glaucoma Society between 30th June and 3rd July.

Prof. Dr Christoph Hirneiß presents MINIject at DOC 2021 digital

The DOC (Deutsche Gesellschaft für Ophthalmochirurgie e.V.) are holding their 33rd International Congress of German Ophthalmic Surgeons as a digital event this year from 17 to 19 June 2021. The congress includes an extensive programme with scientific sessions on glaucoma surgery.

MINIject presented at MIGS Symposium 2021

MINIjectTM, iSTAR Medical’s minimally invasive glaucoma surgery (MIGS) device, will be presented in two lectures at the upcoming MIGS Symposium 2021 on Saturday, 17th April from 11:00AM to 2:30PM CET.